Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Revenue (2016 - 2023)

Lite Strategy (LITS) posted Revenue of $65.3 million for Q3 2023, up 4381.61% on a QoQ basis from $1.5 million in Q2 2023, and up 647.96% year-over-year from $8.7 million in Q3 2022.

Analysis

Lite Strategy (LITS) Revenue (2016 - 2023) Analysis & Trends

Lite Strategy has reported Revenue for 8 years, with the latest figure at $65.3 million in Q3 2023.

  • On a quarterly basis, Revenue rose 647.96% year-over-year to $65.3 million in Q3 2023; TTM through Jun 2024 was $65.3 million, a 33.76% increase from a year earlier, with the FY2024 full-year figure at $65.3 million, up 33.76% from the prior year.
  • Revenue was $65.3 million for Q3 2023 at Lite Strategy, up from $1.5 million in the prior quarter.
  • The five-year high for Revenue was $65.3 million in Q3 2023, with the low at $1.0 million in Q4 2019.
  • Average Revenue over 5 years is $11.6 million, with a median of $7.8 million recorded in 2021.
  • The sharpest annual moves came in 2020 and 2023: Revenue soared 2158.99% in 2020, then plunged 87.23% in 2023.
  • Over 5 years, Revenue stood at $1.0 million in 2019, then soared by 1149.5% to $12.6 million in 2020, then fell by 6.06% to $11.8 million in 2021, then soared by 176.66% to $32.7 million in 2022, then jumped by 99.47% to $65.3 million in 2023.
  • The last three Revenue figures came in at $65.3 million (Q3 2023), $1.5 million (Q2 2023), and $5.9 million (Q1 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.29 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.74 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 1.44 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 65.30 Mn
Jun 30, 2023 1.46 Mn
Mar 31, 2023 5.89 Mn
Dec 31, 2022 32.74 Mn
Sep 30, 2022 8.73 Mn
Jun 30, 2022 11.41 Mn
Mar 31, 2022 9.69 Mn
Dec 31, 2021 11.83 Mn
Sep 30, 2021 7.76 Mn
Jun 30, 2021 7.45 Mn
Mar 31, 2021 8.11 Mn
Dec 31, 2020 12.60 Mn
Sep 30, 2020 6.64 Mn
Jun 30, 2020 25.50 Mn
Mar 31, 2020 1.24 Mn
Dec 31, 2019 1.01 Mn
Sep 30, 2019 1.16 Mn
Jun 30, 2019 1.13 Mn
Mar 31, 2019 1.25 Mn
Dec 31, 2018 2.05 Mn